{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:39:25Z","timestamp":1789706365140,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":1442,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA14089-27S1"],"award-info":[{"award-number":["P30CA14089-27S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006508","name":"Dhont Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006508","id-type":"DOI","asserted-by":"publisher"}]},{"name":"San Pedro Peninsula Cancer Guild"},{"name":"Mildred-Scheel Foundation"},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swiss Cancer League","award":["BIL KLS-3334-02-2014"],"award-info":[{"award-number":["BIL KLS-3334-02-2014"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1093\/annonc\/mdv474","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:23:34Z","timestamp":1443486214000},"page":"2450-2456","source":"Crossref","is-referenced-by-count":51,"title":["Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials"],"prefix":"10.1016","volume":"26","author":[{"given":"Y.","family":"Sunakawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Stintzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cremolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Stremitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Matsusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Graver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Loupakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-J.","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdv474_bb0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"10.1093\/annonc\/mdv474_bb0015","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1093\/annonc\/mdv474_bb0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ni.2060","article-title":"Inflammation meets cancer, with NF-kappaB as the matchmaker","volume":"12","author":"Ben-Neriah","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1093\/annonc\/mdv474_bb0025","first-page":"7042","article-title":"Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process","volume":"62","author":"Barbera-Guillem","year":"2002","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdv474_bb0030","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1158\/1078-0432.CCR-06-2073","article-title":"High macrophage infiltration along the tumor front correlates with improved survival in colon cancer","volume":"13","author":"Forssell","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdv474_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12307-010-0052-5","article-title":"Tumor-associated macrophages (TAM) and inflammation in colorectal cancer","volume":"4","author":"Erreni","year":"2011","journal-title":"Cancer Microenviron"},{"key":"10.1093\/annonc\/mdv474_bb0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/annonc\/mdu542","article-title":"Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer","volume":"26","author":"Sunakawa","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdv474_bb0045","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1403108","article-title":"Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer","volume":"371","author":"Loupakis","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdv474_bb0050","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S1470-2045(14)70330-4","article-title":"FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial","volume":"15","author":"Heinemann","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdv474_bb0055","doi-asserted-by":"crossref","first-page":"D820","DOI":"10.1093\/nar\/gkm904","article-title":"F-SNP: computationally predicted functional SNPs for disease association studies","volume":"36","author":"Lee","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1093\/annonc\/mdv474_bb0060","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.4049\/jimmunol.171.8.4304","volume":"171","author":"Sato","year":"2003","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/mdv474_bb0065","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.0511319103","article-title":"Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway","volume":"103","author":"Korherr","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdv474_bb0070","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"10.1093\/annonc\/mdv474_bb0075","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/2159-8290.CD-12-0595","article-title":"PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy","volume":"3","author":"Tan","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1093\/annonc\/mdv474_bb0080","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.4049\/jimmunol.160.3.1411","article-title":"Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern","volume":"160","author":"Kodelja","year":"1998","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/mdv474_bb0085","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/sj.gene.6364449","article-title":"IRF-3-dependent and augmented target genes during viral infection","volume":"9","author":"Andersen","year":"2008","journal-title":"Genes Immun"},{"key":"10.1093\/annonc\/mdv474_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1093\/annonc\/mdv474_bb0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.18632\/oncotarget.240","article-title":"Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health","volume":"2","author":"Chappell","year":"2011","journal-title":"Oncotarget"},{"key":"10.1093\/annonc\/mdv474_bb0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ccr.2004.09.028","article-title":"Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis","volume":"6","author":"Sparmann","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1093\/annonc\/mdv474_bb0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bcp.2011.11.013","article-title":"CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras\/Raf\/MEK\/ERK\/NF-kappaB signaling pathway","volume":"83","author":"Tang","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1093\/annonc\/mdv474_bb0110","doi-asserted-by":"crossref","first-page":"e73616","DOI":"10.1371\/journal.pone.0073616","article-title":"Differential expression of IL-17, 22 and 23 in the progression of colorectal cancer in patients with K-ras mutation: Ras signal inhibition and crosstalk with GM-CSF and IFN-gamma","volume":"8","author":"Petanidis","year":"2013","journal-title":"PLoS One"},{"key":"10.1093\/annonc\/mdv474_bb0115","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2217\/pgs.13.169","article-title":"Concordance of genotype for polymorphisms in DNA isolated from peripheral blood and colorectal cancer tumor samples","volume":"14","author":"van Huis-Tanja","year":"2013","journal-title":"Pharmacogenomics"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341935728X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341935728X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/26\/12\/2450\/16700258\/mdv474.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T17:53:32Z","timestamp":1692035612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341935728X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S092375341935728X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdv474","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}